SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-010417
Filing Date
2023-08-10
Accepted
2023-08-10 08:01:23
Documents
14
Period of Report
2023-08-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ndra_8k.htm   iXBRL 8-K 35787
  Complete submission text file 0001654954-23-010417.txt   159563

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ndra-20230809.xsd EX-101.SCH 5735
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20230809_lab.xml EX-101.LAB 14667
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20230809_cal.xml EX-101.CAL 908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20230809_pre.xml EX-101.PRE 9285
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20230809_def.xml EX-101.DEF 2109
8 EXTRACTED XBRL INSTANCE DOCUMENT ndra_8k_htm.xml XML 3604
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 231157249
SIC: 3845 Electromedical & Electrotherapeutic Apparatus